Arito Yamane
Overview
Explore the profile of Arito Yamane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
3257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kouzine F, Wojtowicz D, Yamane A, Casellas R, Przytycka T, Levens D
Methods Mol Biol
. 2019 Aug;
2035:369-382.
PMID: 31444763
While DNA inside the cells is predominantly canonical right-handed double helix, guanine-rich DNAs have potential to fold into four-stranded structures that contain stacks of G-quartets (G4 DNA quadruplex). Genome sequencing...
2.
Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, et al.
Oncotarget
. 2019 Mar;
10(13):1306-1319.
PMID: 30863491
Introduction: Thymic epithelial tumors (TETs) comprise several histologies of thymoma and thymic carcinomas (TCs), and TC frequently metastasizes and causes death. We therefore aimed here to identify key molecules closely...
3.
Handa T, Katayama A, Yokobori T, Yamane A, Fujii T, Obayashi S, et al.
Int J Oncol
. 2019 Jan;
54(3):833-844.
PMID: 30628666
Using whole transcriptome analysis and a lentiviral short hairpin RNA screening library, carboxypeptidase A4 (CPA4) was identified as a novel marker in breast cancer and a therapeutic target in triple‑negative...
4.
Horigome E, Fujieda M, Handa T, Katayama A, Ito M, Ichihara A, et al.
Oncotarget
. 2018 Oct;
9(77):34554-34566.
PMID: 30349649
Purpose: The identification of genes with synthetic lethality in the context of mutant TP53 is a promising strategy for the treatment of basal-like triple negative breast cancer (TNBC). This study...
5.
Handa T, Katayama A, Yokobori T, Yamane A, Horiguchi J, Kawabata-Iwakawa R, et al.
J Surg Oncol
. 2017 Jun;
116(6):706-715.
PMID: 28570747
Background And Objectives: The Caspase14 (CASP14) was reported that the low expression of CASP14 in ovarian cancer and colon cancer was associated with cancer progression, on the other hand, that...
6.
Tahara K, Takizawa M, Yamane A, Osaki Y, Ishizaki T, Mitsui T, et al.
Cancer Sci
. 2017 May;
108(8):1556-1564.
PMID: 28544233
B-cell lymphoma 6 (BCL6) attenuates DNA damage response (DDR) through gene repression and facilitates tolerance to genomic instability during immunoglobulin affinity maturation in germinal center (GC) B cells. Although BCL6...
7.
Kouzine F, Wojtowicz D, Baranello L, Yamane A, Nelson S, Resch W, et al.
Cell Syst
. 2017 Feb;
4(3):344-356.e7.
PMID: 28237796
DNA in cells is predominantly B-form double helix. Though certain DNA sequences in vitro may fold into other structures, such as triplex, left-handed Z form, or quadruplex DNA, the stability...
8.
Zhang S, Zhu I, Deng T, Furusawa T, Rochman M, Vacchio M, et al.
Nucleic Acids Res
. 2016 Apr;
44(15):7144-58.
PMID: 27112571
The activation of naïve B lymphocyte involves rapid and major changes in chromatin organization and gene expression; however, the complete repertoire of nuclear factors affecting these genomic changes is not...
9.
Tsuboi M, Yamane A, Horiguchi J, Yokobori T, Kawabata-Iwakawa R, Yoshiyama S, et al.
Breast Cancer
. 2015 Oct;
23(5):780-8.
PMID: 26476745
Background: The members of AID/APOBEC protein family possess cytidine deaminase activity that converts cytidine residue to uridine on DNA and RNA. Recent studies have shown the possible influence of APOBEC3B...
10.
Teng G, Maman Y, Resch W, Kim M, Yamane A, Qian J, et al.
Cell
. 2015 Aug;
162(4):751-65.
PMID: 26234156
The RAG1 endonuclease, together with its cofactor RAG2, is essential for V(D)J recombination but is a potent threat to genome stability. The sources of RAG1 mis-targeting and the mechanisms that...